Related references
Note: Only part of the references are listed.Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations
Ching-Hsuan Chen et al.
ONCOLOGIST (2020)
European polygenic risk score for prediction of breast cancer shows similar performance in Asian women
Weang-Kee Ho et al.
NATURE COMMUNICATIONS (2020)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China
Mei Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M. Rueda et al.
NATURE (2019)
Comparison of breast cancer risk factors among molecular subtypes: A case-only study
Liwen Zhang et al.
CANCER MEDICINE (2019)
Insights Into Breast Cancer in the East vs the West: A Review
Yoon-Sim Yap et al.
JAMA ONCOLOGY (2019)
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Yochai Wolf et al.
CELL (2019)
MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population
Lenora W. M. Loo et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics
Libby Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Strelka2: fast and accurate calling of germline and somatic variants
Sangtae Kim et al.
NATURE METHODS (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Zhengyan Kan et al.
NATURE COMMUNICATIONS (2018)
Structural absorption by barbule microstructures of super black bird of paradise feathers
Dakota E. McCoy et al.
NATURE COMMUNICATIONS (2018)
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial
Stephen J. Luen et al.
JAMA ONCOLOGY (2018)
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Noam Auslander et al.
NATURE MEDICINE (2018)
A case-control study of breast cancer risk factors in 7,663 women in Malaysia
Min-Min Tan et al.
PLOS ONE (2018)
Amplification of chirality in surface-confined supramolecular bilayers
Hai Cao et al.
NATURE COMMUNICATIONS (2018)
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Jason J. Pitt et al.
NATURE COMMUNICATIONS (2018)
Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population
Mustapha Abubakar et al.
BREAST CANCER RESEARCH (2018)
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam et al.
JCO PRECISION ONCOLOGY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
Jarno Drost et al.
SCIENCE (2017)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
Olivier Brouckaert et al.
BREAST CANCER RESEARCH (2017)
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Jie Sun et al.
CLINICAL CANCER RESEARCH (2017)
Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes
Scarlett Lin Gomez et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Clinical outcomes based on multigene profiling in metastatic breast cancer patients
Reva K. Basho et al.
ONCOTARGET (2016)
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
Jasreet Hundal et al.
GENOME MEDICINE (2016)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Cancer-Specific Mortality of Asian Americans Diagnosed With Cancer: A Nationwide Population-Based Assessment
Quoc-Dien Trinh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Cancer-Specific Mortality of Asian Americans Diagnosed With Cancer: A Nationwide Population-Based Assessment
Quoc-Dien Trinh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Sarah L. Maguire et al.
JOURNAL OF PATHOLOGY (2015)
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Laxmi Silwal-Pandit et al.
CLINICAL CANCER RESEARCH (2014)
DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly
Ilari Scheinin et al.
GENOME RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
PyClone: statistical inference of clonal population structure in cancer
Andrew Roth et al.
NATURE METHODS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry
Melinda L. Telli et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
Andrew E. Teschendorff et al.
BMC CANCER (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
